11C-UCB-J, 18F-DPA-714, [11C]PiB
D23-P006
Phase 2 small_molecule active
Quick answer
11C-UCB-J, 18F-DPA-714, [11C]PiB for Alzeihmer disease is a Phase 2 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pari Pharma GmbH
- Indication
- Alzeihmer disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active